Vivos Therapeutics (VVOS) Free Cash Flow (2020 - 2026)
Vivos Therapeutics (VVOS) reported Free Cash Flow of -$6.0 million for Q1 2026, down 53.85% year-over-year from -$13.1 million in Q1 2025, and up 25.93% on a QoQ basis from -$8.1 million in Q4 2025.
Vivos Therapeutics (VVOS) has 7 years of Free Cash Flow data on file, last reported at -$6.0 million in Q1 2026.
- Quarterly Free Cash Flow fell 53.85% year-over-year to -$6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$22.6 million (down 55.47% YoY) and the FY2025 annual result came in at -$20.4 million, down 54.22% from the prior year.
- Free Cash Flow climbed to -$6.0 million in Q1 2026 per VVOS's latest filing, from -$8.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$2.1 million in Q4 2023 and bottomed at -$8.1 million in Q4 2025.
- The 5-year median for Free Cash Flow is -$3.9 million (2025), against an average of -$4.2 million.
- The widest annual swing landed in 2023, when Free Cash Flow jumped 50.77%; it then slumped 162.09% in 2025.
- Tracing VVOS's Free Cash Flow over 5 years: stood at -$3.2 million in 2022, then surged by 33.73% to -$2.1 million in 2023, then slumped by 47.02% to -$3.1 million in 2024, then plunged by 162.09% to -$8.1 million in 2025, then increased by 25.93% to -$6.0 million in 2026.
- Per Business Quant, the three latest VVOS Free Cash Flow figures stand at -$6.0 million (Q1 2026), -$8.1 million (Q4 2025), and -$4.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | -6.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.03 Mn |
| Mar 31, 2026 | -6.03 Mn |
| Dec 31, 2025 | -5.29 Mn |
| Dec 31, 2025 | -5.29 Mn |
| Sep 30, 2025 | -4.12 Mn |
| Sep 30, 2025 | -4.12 Mn |
| Jun 30, 2025 | -4.28 Mn |
| Jun 30, 2025 | -4.28 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Dec 31, 2024 | -3.07 Mn |
| Dec 31, 2024 | -3.07 Mn |
| Sep 30, 2024 | -4.39 Mn |
| Sep 30, 2024 | -4.39 Mn |
| Jun 30, 2024 | -3.16 Mn |
| Jun 30, 2024 | -3.16 Mn |
| Mar 31, 2024 | -2.65 Mn |
| Mar 31, 2024 | -2.65 Mn |
| Dec 31, 2023 | -2.70 Mn |
| Dec 31, 2023 | -2.70 Mn |
| Sep 30, 2023 | -2.80 Mn |
| Sep 30, 2023 | -2.80 Mn |
| Jun 30, 2023 | -2.86 Mn |
| Jun 30, 2023 | -2.86 Mn |
| Mar 31, 2023 | -3.59 Mn |
| Mar 31, 2023 | -3.59 Mn |
| Dec 31, 2022 | -3.20 Mn |
| Dec 31, 2022 | -3.20 Mn |
| Sep 30, 2022 | -6.00 Mn |
| Sep 30, 2022 | -6.00 Mn |
| Jun 30, 2022 | -5.10 Mn |
| Jun 30, 2022 | -5.10 Mn |
| Mar 31, 2022 | -6.22 Mn |
| Mar 31, 2022 | -6.22 Mn |
| Dec 31, 2021 | -2.22 Mn |
| Dec 31, 2021 | -2.22 Mn |
| Sep 30, 2021 | -4.50 Mn |
| Sep 30, 2021 | -4.50 Mn |
| Jun 30, 2021 | -4.97 Mn |
| Jun 30, 2021 | -4.97 Mn |
| Mar 31, 2021 | -4.16 Mn |
| Mar 31, 2021 | -4.16 Mn |
| Dec 31, 2020 | -3.62 Mn |
| Dec 31, 2020 | -3.62 Mn |
| Sep 30, 2020 | -686,445.00 |
| Sep 30, 2020 | -686,445.00 |
| Jun 30, 2020 | -958,400.00 |
| Jun 30, 2020 | -958,400.00 |
| Mar 31, 2020 | -442,114.00 |
| Mar 31, 2020 | -442,114.00 |